Kodiak Sciences Inc (KOD)

9.20 -0.37 (-3.87%) USD  |  NASDAQ  |  Jan 08, 16:00
9.38 +0.18 (+1.96%) After-Hours: 20:00
More

Kodiak Sciences SG&A Expense (Quarterly): 14.75M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for KOD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Pfizer Inc 3.244B
Regeneron Pharmaceuticals Inc 714.40M
Revance Therapeutics Inc 62.22M
Editas Medicine Inc 18.09M
Arcutis Biotherapeutics Inc 58.82M